Pharma Outsourcing to Touch $2.3b
August 15, 2009, The Economic Times


Riding over lower manufacturing costs and availability of quality manpower with technical capabilities, the Indian
pharmaceutical outsourcing industry is expected to touch $2.3 billion by the end of the 2010, according to a report, jointly prepared by global consultancy firm Ernst & Young and industry body OPPI, said Indian  pharmaceutical contract manufacturing industry is growing at thrice the rate of the global outsourcing market, and is expected to reach $2.3 billion from $1.1 billion in 2008. “India scores well on its ability to create a differentiating cost value proposition, powered by its lower manufacturing cost and manpower and technical  capabilities, but it needs to improve on its culture of environment and health safety compliance and infrastructure,” the report said